Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01022437
Other study ID # PBRC 28041
Secondary ID
Status Completed
Phase N/A
First received November 25, 2009
Last updated December 17, 2015
Start date December 2008
Est. completion date October 2011

Study information

Verified date December 2015
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study is designed to evaluate the effectiveness of geranium oil and its components in the relief of numbness and the restoration of sensations.


Description:

This is a pilot study to define the time course, the incidence of sensation restoration and the improvement in nerve conduction in people with numbness by using topical geranium oil.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date October 2011
Est. primary completion date October 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Neuropathy with the inability to feel touch in a standard nylon filament test

- Signed informed consent

Exclusion Criteria:

- Pregnant or nursing

- Known allergies to geranium oil or geranium oil fractions

- Open sore in the area of numbness

- Migraine headaches or headaches to strong smells

Study Design

Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Geranium Oil with component PN-34
Geranium oil as a topical application to the body that is numb, time to determine how long it takes for the feeling to return, if it does so, and if the return of feeling is maintained by daily topical application of oil over 12 weeks. This including the process of absorption, distribution and localization.

Locations

Country Name City State
United States Penningto Biomedical Research Center Baton Rouge Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Response to numbness relief and restoration of sensation 12 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03943498 - Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy Early Phase 1
Recruiting NCT06094257 - Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
Terminated NCT03206216 - Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN N/A
Completed NCT02194036 - Learning Oriented Physiotherapy - a New Approach N/A